Home » Topics » BioWorld Science

BioWorld Science
RSS

Second pivotal trial for Carrington's ulcerative colitis product

Sep. 20, 1996

Novel proton pump inhibitors from Dainippon

Sep. 20, 1996

NC-1800 advances through clinical trials

Sep. 20, 1996

New agents for BPH from Abbott

Sep. 20, 1996

Merck & Co. continues to investigate 5alpha-reductase inhibitors

Sep. 20, 1996

Antiplatelet ketoprofen analogue from Fuji Chem.

Sep. 20, 1996

Bristol-Myers Squibb to acquire prostacyclin analogue for claudication

Sep. 20, 1996

New prostacyclins from Asahi Glass

Sep. 20, 1996

Anticoagulant for treating blood clots approved in Canada

Sep. 20, 1996

Calcium-antagonist effects of estrogen

Sep. 20, 1996

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...